Prabhat Sinha is a seasoned healthcare policy, public affairs, and stakeholder engagement leader currently serving as Head of Corporate Affairs at Takeda India, where he leads strategic initiatives across government relations, policy advocacy, corporate communications, patient engagement, and reputation management for one of the world’s leading biopharmaceutical organizations. With more than two decades of progressive experience across healthcare, pharmaceuticals, public health, and development sectors, he has established himself as a respected voice in advancing patient-centric healthcare ecosystems and strengthening policy frameworks in India.

At Takeda, Prabhat is responsible for aligning the company’s strategic priorities with India’s evolving healthcare and regulatory landscape, while fostering trusted partnerships with policymakers, healthcare institutions, industry associations, and patient communities. His leadership is focused on creating sustainable policy environments that improve access to innovative therapies, particularly in specialized and underserved therapeutic segments such as rare diseases and advanced biopharmaceuticals.

Before joining Takeda, he served as Director – Government and Public Affairs at Boehringer Ingelheim India, where he played a key role in strategic policy engagement and health system strengthening initiatives. Earlier, he held leadership roles at Pfizer, Novartis Oncology, Novo Nordisk, and Eli Lilly, contributing significantly to public affairs, patient advocacy, and corporate communication strategies across non-communicable diseases, specialty healthcare, and access programs. His work consistently emphasized collaboration between industry, public institutions, and civil society to improve healthcare outcomes.

Prabhat’s professional journey also includes impactful contributions in the development sector through organizations such as CARE India and Sightsavers, reflecting a broader commitment to inclusive healthcare and social impact. This multidisciplinary experience has given him a unique ability to bridge public health priorities with corporate strategy, making him particularly effective in navigating complex healthcare ecosystems.
Known for his strengths in policy advocacy, corporate diplomacy, and patient-centered leadership, Prabhat Sinha continues to shape meaningful dialogue at the intersection of healthcare innovation, governance, and societal impact—helping drive Takeda’s mission of delivering better health and a brighter future for patients.